Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 4c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.80), $0.04 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins